Abstract Number: 1226 • 2015 ACR/ARHP Annual Meeting
Assessing the Possible Association of Anti-TNF Use with New Neoplasms: An Important Methodological Consideration
Background/Purpose: Whether anti- TNF agents increase the frequency of neoplasms remains debated. The drug regulatory agencies still mandate black boxes on the related package inserts…Abstract Number: 1227 • 2015 ACR/ARHP Annual Meeting
Discrepancies Between Registered and Published Primary Outcomes in Randomized Controlled Trials of Rheumatoid Arthritis
Background/Purpose: Selective outcome reporting may bias treatment effect estimates of clinical trials. Registration of clinical trials was established to improve transparency in their conduct and…Abstract Number: 1228 • 2015 ACR/ARHP Annual Meeting
Estimating Under-Diagnosis of Rheumatoid Arthritis in Primary Care Data from the UK Clinical Practice Research Datalink
Background/Purpose: The prevalence of rheumatoid arthritis (RA) in primary care electronic health records (EHRs) is much lower than patient self-reports from population surveys, which may…Abstract Number: 1229 • 2015 ACR/ARHP Annual Meeting
Regional Variation in Measured Detection of Ankylosing Spondylitis
Background/Purpose: Patients suffering from ankylosing spondylitis (AS) often receive a delayed or mis-diagnosis, as this condition is frequently confused with mechanical back pain from other…Abstract Number: 1230 • 2015 ACR/ARHP Annual Meeting
Only One-Third of Patients with Spondyloarthritis Are Managed By Rheumatologists
Background/Purpose: The prevalence of Ankylosing Spondylitis (AS) in Europe has been estimated in a number of studies, some based on clinic populations, others from general…Abstract Number: 1231 • 2015 ACR/ARHP Annual Meeting
The Prevalence of Non-Radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain in Rheumatology Practices
Background/Purpose: The diagnosis of Ankylosing Spondylitis (AS) is delayed by >10 years after the symptoms develop, as by definition the modified NY criteria for classification…Abstract Number: 1232 • 2015 ACR/ARHP Annual Meeting
Prevalence of Idiopathic Inflammatory Myopathies in Sweden in 2012 – a National Register Study
Background/Purpose: Overall prevalence of idiopathic inflammatory myopathies (IIM) is commonly reported at 10 per 100,000 but worldwide estimates vary between 1 and 25 per 100,000…Abstract Number: 1233 • 2015 ACR/ARHP Annual Meeting
Epidemiology of GCA in Bergen (Western Norway) 1972-2012
Background/Purpose: Giant cell arteritis (GCA) is the most common systemic vasculitis in persons older than 50 years. The highest incidence rates of the disease have…Abstract Number: 1234 • 2015 ACR/ARHP Annual Meeting
Epidemiology of Sarcoidosis 1976-2013: A Population-Based Study
Epidemiology of Sarcoidosis 1976-2013: A Population-Based StudyBackground/Purpose: The epidemiology of sarcoidosis is not well-described. Only coding-based studies with point estimates over relatively short periods, without…Abstract Number: 1235 • 2015 ACR/ARHP Annual Meeting
Epidemiology of Kikuchi-Fujimoto Disease in Martinique and Characteristics in an Afro-Caribbean Population: Close Relation with Lupus
Background/Purpose: Kikuchi-Fujimoto disease (KFD) is a rare histiocytic necrotizing lymphadenitis affecting mainly Asian young women, associated to systemic lupus (SLE) in less than 25% of…Abstract Number: 1236 • 2015 ACR/ARHP Annual Meeting
Google-Driven Search for Autoimmune Big Data Links Air Pollution and Younger Age at Diagnosis of Systemic Lupus Erythematosus: Geoepidemiological Analysis of 171,000 Adult Patients
Background/Purpose: Systemic autoimmune diseases (SAD) are characterized by a wide spectrum of demographic patterns with respect to the age at diagnosis, gender distribution and ethnic differences.…Abstract Number: 1237 • 2015 ACR/ARHP Annual Meeting
The Incidence and Prevalence of Systemic Lupus Erythematous in a Defined Population in United Arab Emirates
Background/Purpose: There is a paucity of information about the incidence and prevalence of systemic lupus erythematosus (SLE) in United Arab Emirates (UAE) and Arab countries.…Abstract Number: 1238 • 2015 ACR/ARHP Annual Meeting
Incident Systemic Lupus Erythematosus in Males in a Northern California County Hospital
Background/Purpose: Little is known about males with systemic lupus erythematosus (SLE), particularly among those with a recent diagnosis. To better understand the presentation and outcomes…Abstract Number: 1239 • 2015 ACR/ARHP Annual Meeting
Significant Impact of Microrna-Target Gene Networks on the Genetics of Rheumatoid Arthritis
Background/Purpose: MicroRNA (miRNA), a short endogenous noncoding RNA, has a major role in the degradation and translational repression of a specific gene through its binding…Abstract Number: 1240 • 2015 ACR/ARHP Annual Meeting
Systematic Protein-Protein Interaction and Pathway Analyses in the Idiopathic Inflammatory Myopathies
Background/Purpose: The idiopathic inflammatory myopathies (IIM) are autoimmune diseases characterised by acquired proximal muscle weakness, inflammatory cell infiltrates in muscle and myositis-specific/associated autoantibodies (MSA/MAA). The…
ACR Meeting Abstracts